Last reviewed · How we verify
BBP-711
At a glance
| Generic name | BBP-711 |
|---|
| Sponsor | Cantero Therapeutics, a BridgeBio company |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.